Whalegun
List

Fact Sheet: President Donald J. Trump Announces Lower Drug Prices for All 50 State Medicaid Programs

Fact sheetPublished 09/18Open the original

Summary

President Trump announces that all 50 state Medicaid programs will get lower drug prices under his most-favored-nation agreements. Under the GENEROUS Medicaid Payment Model, participating manufacturers give rebates on expensive brand-name drugs so Medicaid's final price does not exceed the MFN price.

By industry

Day by day after the announcement

Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
DayHealthcare & Drug Pricing stocksS&P 500
26/09/170.0%0.0%
26/09/18−0.2%+0.1%
26/09/21+0.3%+1.5%
26/09/22+0.5%+1.4%
26/09/23−0.4%+0.8%
26/09/24−0.4%+0.6%
26/09/25+0.4%+1.2%
26/09/28+0.4%+0.4%
26/09/29+0.4%+0.4%
26/09/30−0.8%+0.3%
26/10/01−1.2%+0.2%

Stocks it names

Korean stocks in these industries

  • Samsung Biologics 207940
  • Celltrion 068270
  • SK Biopharmaceuticals 326030

Trades in these industries around the announcement

Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.

  • Kevin Hern

    Full saleUnitedhealth Group

    $15K–$50K

    Reported 09/25

  • Pete Sessions

    Full saleAbbVie

    $15K–$50K

    Reported 09/18

  • Thomas H. Kean Jr.

    Partial saleJohnson & Johnson

    $1K–$15K

    Reported 09/12

  • John Boozman

    Partial saleJohnson & Johnson

    $1K–$15K

    Reported 09/11

  • David Taylor

    Full saleAmgen

    $1K–$15K

    Reported 09/05

  • David Taylor

    Full saleAmgen

    $1K–$15K

    Reported 09/05

  • Maria Salazar

    BuyMerck

    $15K–$50K

    Reported 09/09

  • Maria Salazar

    BuyMerck

    $15K–$50K

    Reported 09/09

Fact Sheet: President Donald J. Trump Announces Lower Drug Prices for All 50 State Medicaid Programs | Whalegun